Legend Biotech Corp Working Capital to Net Assets Ratio
Legend Biotech Corp working capital to net assets ratio. Legend Biotech Corp (LEGN) has a Working Capital to Net Assets ratio of 67.0% as of June 2026. Working capital of $823.83 Million (current assets of $1.23 Billion minus current liabilities of $403.61 Million) is measured against net assets of $1.23 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Legend Biotech Corp (2017–2025)
Working capital to net assets ratio of Legend Biotech Corp from 2017 to 2025. This chart shows how Legend Biotech Corp's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the ratio stands at 67.0%, reflecting working capital of $823.83 Million against net assets of $1.23 Billion USD. Explore Legend Biotech Corp (LEGN) long-term investment share to see how much of total assets are deployed in long-term investments.
Legend Biotech Corp Working Capital to Net Assets Ratio by Year (2017–2025)
Legend Biotech Corp working capital to net assets ratio by year from 2017 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Legend Biotech Corp from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Legend Biotech Corp balance sheet assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 60.9% | $610.70 Million | $1.00 Billion | $1.25 Billion | $636.40 Million | ▼ -35.8 pp |
| 2024 | 96.7% | $1.01 Billion | $1.04 Billion | $1.28 Billion | $277.64 Million | ▼ -5.7 pp |
| 2023 | 102.4% | $1.28 Billion | $1.25 Billion | $1.50 Billion | $216.42 Million | ▼ -5.3 pp |
| 2022 | 107.7% | $801.33 Million | $744.31 Million | $1.10 Billion | $297.79 Million | ▲ +13.6 pp |
| 2021 | 94.1% | $720.65 Million | $765.94 Million | $949.85 Million | $229.20 Million | ▲ +14.3 pp |
| 2020 | 79.8% | $478.38 Million | $599.82 Million | $593.94 Million | $115.57 Million | ▲ +144.3 pp |
| 2019 | -64.6% | $79.34 Million | $-122.87 Million | $207.10 Million | $127.76 Million | ▼ -2004.3 pp |
| 2018 | 1939.8% | $167.77 Million | $8.65 Million | $326.96 Million | $159.19 Million | ▲ +470.3 pp |
| 2017 | 1469.5% | $178.78 Million | $12.17 Million | $230.90 Million | $52.12 Million | — |